Haematocrit, viscosity, erythrocyte sedimentation rate: meta-analyses of prospective studies of coronary heart disease

Blood pressure, stroke, and coronary heart disease *1Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias

MACMAHON, S. (1990) · The Lancet · doi:10.1016/0140-6736(90)90878-9 · Cited by 4,253 · cited 1×

Publication bias in clinical research

Easterbrook, P. J., Gopalan, R., Berlin, J. A., & Matthews, D. R. (1991) · The Lancet · doi:10.1016/0140-6736(91)90201-y · Cited by 3,109 · cited 2×

Association of Fibrinogen, C-reactive Protein, Albumin, or Leukocyte Count With Coronary Heart Disease

Danesh, J., Collins, R., Appleby, P. N., & Peto, R. (1998) · JAMA · doi:10.1001/jama.279.18.1477 · Cited by 2,027

Underestimation of Risk Associations Due to Regression Dilution in Long-term Follow-up of Prospective Studies

Clarke, R., Shipley, M. J., Lewington, S., Youngman, L. D., Collins, R., Marmot, M. G., & Peto, R. (1999) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a010013 · Cited by 879

Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study

MEADE, T. (1993) · The Lancet · doi:10.1016/0140-6736(93)92062-x · Cited by 711

Blood viscosity and risk of cardiovascular events: the Edinburgh Artery Study

Lowe, G. D. O., Lee, A. J., Rumley, A., Price, J. F., & Fowkes, F. G. R. (1997) · British Journal of Haematology · doi:10.1046/j.1365-2141.1997.8532481.x · Cited by 550

Influence of platelet size on outcome after myocardial infarction

Martin, J. F., Bath, P. M., & Burr, M. L. (1991) · The Lancet · doi:10.1016/0140-6736(91)92719-i · Cited by 494

Hematocrit and the risk of cardiovascular disease—The Framingham Study: A 34-year follow-up

GAGNON, D. R., Zhang, T., Brand, F. N., & Kannel, W. B. (1994) · American Heart Journal · doi:10.1016/0002-8703(94)90679-3 · Cited by 375

The natural history of coronary heart disease: prognostic factors after recovery from myocardial infarction in 2789 men. The 5-year findings of the coronary drug project.

Schlant, R. C., Forman, S. A., Stamler, J., & Canner, P. L. (1982) · Circulation · doi:10.1161/01.cir.66.2.401 · Cited by 176

Risk factors for myocardial infarction and death due to ischemic heart disease and other causes

Tibblin, G., Wilhelmsen, L., & Werkö, L. (1975) · The American Journal of Cardiology · doi:10.1016/0002-9149(75)90834-6 · Cited by 173

C-Reactive Protein and Other Circulating Markers of Inflammation in the Prediction of Coronary Heart Disease

Danesh, J., Wheeler, J. G., Hirschfield, G. M., Eda, S., Eiriksdottir, G., Rumley, A., Lowe, G. D. O., Pepys, M. B., & Gudnason, V. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032804 · Cited by 2,953

JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice

Prepared, B. (2005) · Heart · doi:10.1136/hrt.2005.079988 · Cited by 1,223

Plasma Fibrinogen Level and the Risk of Major Cardiovascular Diseases and Nonvascular Mortality

Danesh, J., Lewington, S., Thompson, S. G., Lowe, G. D. O., Collins, R., Kostis, J. B., Wilson, A. C., Folsom, A. R., Wu, K., Benderly, M., et al. (2005) · JAMA · doi:10.1001/jama.294.14.1799 · Cited by 1,162

The sex difference in haemoglobin levels in adults—mechanisms, causes, and consequences

Murphy, W. G. (2014) · Blood Reviews · doi:10.1016/j.blre.2013.12.003 · Cited by 463

Physical Activity and Hemostatic and Inflammatory Variables in Elderly Men

Wannamethee, S. G., Lowe, G. D. O., Whincup, P. H., Rumley, A., Walker, M., & Lennon, L. (2002) · Circulation · doi:10.1161/01.cir.0000016346.14762.71 · Cited by 487

Associations between cigarette smoking, pipe/cigar smoking, and smoking cessation, and haemostatic and inflammatory markers for cardiovascular disease

Wannamethee, S. G., Lowe, G. D. O., Shaper, A. G., Rumley, A., LENNON, L. T., & Whincup, P. H. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi183 · Cited by 430

Testosterone induces erythrocytosis via increased erythropoietin and suppressed hepcidin: evidence for a new erythropoietin/hemoglobin set point

Bachman, E., Travison, T. G., Basaria, S., Davda, M. N., Guo, W., Li, M., Connor Westfall, J., Bae, H., Gordeuk, V., & Bhasin, S. (2014) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glt154 · Cited by 426

Red blood cells in thrombosis

Byrnes, J. R., & Wolberg, A. S. (2017) · Blood · doi:10.1182/blood-2017-03-745349 · Cited by 346

Virchow’s Triad Revisited: Abnormal Flow

Lowe, G. D. O. (2003) · Pathophysiology of Haemostasis and Thrombosis · doi:10.1159/000083845 · Cited by 278

Which Hemostatic Markers Add to the Predictive Value of Conventional Risk Factors for Coronary Heart Disease and Ischemic Stroke?

Smith, A. D., Patterson, C., Yarnell, J., Rumley, A., Ben‐Shlomo, Y., & Lowe, G. D. O. (2005) · Circulation · doi:10.1161/circulationaha.105.557132 · Cited by 256

Relative Value of Inflammatory, Hemostatic, and Rheological Factors for Incident Myocardial Infarction and Stroke

Tzoulaki, I., Murray, G. D., Lee, A. J., Rumley, A., Lowe, G. D. O., & Fowkes, F. G. R. (2007) · Circulation · doi:10.1161/circulationaha.106.635029 · Cited by 238

Profile of the Immune and Inflammatory Response in Individuals With Prediabetes and Type 2 Diabetes

Grossmann, V., Schmitt, V. H., Zeller, T., Panova-Noeva, M., Schulz, A., Laubert-Reh, D., Juenger, C., Schnabel, R. B., Abt, T. G. J., Laskowski, R., et al. (2015) · Diabetes Care · doi:10.2337/dc14-3008 · Cited by 257

Plasma leptin: Associations with metabolic, inflammatory and haemostatic risk factors for cardiovascular disease

Wannamethee, S. G., Tchernova, J., Whincup, P. H., Lowe, G. D. O., Kelly, A., Rumley, A., Wallace, A. M., & Sattar, N. A. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.04.012 · Cited by 210

The Genetic Architecture of Adaptations to High Altitude in Ethiopia

Alkorta‐Aranburu, G., Beall, C. M., Witonsky, D., Gebremedhin, A., Pritchard, J. K., & Rienzo, A. D. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1003110 · Cited by 221

Circulating inflammatory markers and risks of cardiovascular and non‐cardiovascular disease

Lowe, G. D. O. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01416.x · Cited by 211

Blood Rheology, Cardiovascular Risk Factors, and Cardiovascular Disease: The West of Scotland Coronary Prevention Study

Rumley, A., Norrie, J. D., Ford, I., Shepherd, J., Cobbe, S. M., Macfarlane, P. W., Packard, C. J., Lowe, G. D. O., & The West of Scotland Coronary Prevention Study Group (2000) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1614066 · Cited by 208

Hematocrit and risk of venous thromboembolism in a general population. The Tromso study

Brækkan, S. K., Mathiesen, E. B., Njølstad, I., Wilsgaard, T., & Hansen, J.-B. (2009) · Haematologica · doi:10.3324/haematol.2009.008417 · Cited by 206

Endothelial dysfunction in insulin resistance and type 2 diabetes

Jansson, P. (2007) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2007.01830.x · Cited by 203

Components of the complete blood count as risk predictors for coronary heart disease: in-depth review and update.

Madjid, M., & Fatemi, O. (2013) · Europe PMC (PubMed Central) · Cited by 194

Blood Donations and Risk of Coronary Heart Disease in Men

Ascherio, A., Rimm, E. B., Giovannucci, E. L., Willett, W. C., & Stampfer, M. J. (2001) · Circulation · doi:10.1161/01.cir.103.1.52 · Cited by 192

Mechanisms Linking Red Blood Cell Disorders and Cardiovascular Diseases

Mozos, I. M. (2015) · BioMed Research International · doi:10.1155/2015/682054 · Cited by 179

Inflammatory, haemostatic, and rheological markers for incident peripheral arterial disease: Edinburgh Artery Study

Tzoulaki, I., Murray, G. D., Lee, A. J., Rumley, A., Lowe, G. D. O., & Fowkes, F. G. R. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehl441 · Cited by 158

Risks and benefits of testosterone therapy in older men

Spitzer, M., Huang, G., Basaria, S., Travison, T. G., & Bhasin, S. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.73 · Cited by 154

European guidelines on cardiovascular disease prevention in clinical practice: third joint task force of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts).

Backer, G. D., Ambrosio, G., Borch‐Johnsen, K., Brotons, C., Cífková, R., Dallongeville, J., Ebrahim, S. B. J., Færgeman, O., Graham, I. D., Mancia, G., et al. (2003) · PubMed · doi:10.1097/01.hjr.0000087913.96265.e2 · Cited by 153

The Relationship Between Infection, Inflammation, and Cardiovascular Disease: An Overview

Lowe, G. D. O. (2001) · Annals of Periodontology · doi:10.1902/annals.2001.6.1.1 · Cited by 144

Diagnostic morphology: biophysical indicators for iron-driven inflammatory diseases

Pretorius, E., & Kell, D. B. (2014) · Integrative Biology · doi:10.1039/c4ib00025k · Cited by 141

Different Effects of Oral and Transdermal Hormone Replacement Therapies on Factor IX, APC Resistance, t-PA, PAI and C-reactive Protein

Upton, M. N., Rumley, A., McConnachie, A., O’Reilly, D., Watt, G. C. M., & Lowe, G. D. O. (2001) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1616085 · Cited by 141

The metabolic syndrome and insulin resistance: relationship to haemostatic and inflammatory markers in older non-diabetic men

Wannamethee, S. G., Lowe, G. D. O., Shaper, A. G., Rumley, A., LENNON, L. T., & Whincup, P. H. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.12.031 · Cited by 135

Proinflammatory Effects of Bacterial Recombinant Human C-Reactive Protein Are Caused by Contamination With Bacterial Products, Not by C-Reactive Protein Itself

Pepys, M. B., Hawkins, P. N., Kahan, M., Tennent, G. A., Gallimore, J. R., Graham, D., Sabin, C. A., Zychlinsky, A., & de Diego, J. (2005) · Circulation Research · doi:10.1161/01.res.0000193595.03608.08 · Cited by 135

Elevated fibrinogen levels and subsequent subclinical atherosclerosis: The CARDIA Study

Green, D., Foiles, N., Chan, C., Schreiner, P. J., & Liu, K. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.05.039 · Cited by 133

Associations of Inflammatory and Hemostatic Variables With the Risk of Recurrent Stroke

Woodward, M., Lowe, G. D. O., Campbell, D. J., Colman, S., Rumley, A., Chalmers, J. P., Neal, B. C., Patel, A. A., Jenkins, A. J., Kemp, B. E., et al. (2005) · Stroke · doi:10.1161/01.str.0000181754.38408.4c · Cited by 129

Erythroid lineage Jak2V617F expression promotes atherosclerosis through erythrophagocytosis and macrophage ferroptosis

Liu, W., Östberg, N. K., Yalçınkaya, M., Dou, H., Endo‐Umeda, K., Tang, Y., Hou, X., Xiao, T., Fidler, T. P., Abramowicz, S., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci155724 · Cited by 130

Hemostatic Risk Factors for Atherothrombotic Disease: An Epidemiologic View

Folsom, A. R. (2001) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1616234 · Cited by 126

Interleukin-6, Fibrin D-Dimer, and Coagulation Factors VII and XIIa in Prediction of Coronary Heart Disease

Lowe, G. D. O., Rumley, A., McMahon, A. D., Ford, I., O’Reilly, D. S. J., & Packard, C. J. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000135995.39488.6c · Cited by 125

Elements of the complete blood count associated with cardiovascular disease incidence: Findings from the EPIC-NL cohort study

Lassale, C., Curtis, A., Abete, I., van der Schouw, Y. T., Verschuren, W. M. M., Lu, Y., & Bueno-de-Mesquita, H. B. (2018) · Scientific Reports · doi:10.1038/s41598-018-21661-x · Cited by 118

Erythrocyte Sedimentation Rate, an Independent Predictor of Coronary Heart Disease in Men and Women: The Reykjavik Study

Andresdottir, M. B. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwg222 · Cited by 118

Burden of Psychosocial Adversity and Vulnerability in Middle Age: Associations With Biobehavioral Risk Factors and Quality of Life

Steptoe, A., & Marmot, M. G. (2003) · Psychosomatic Medicine · doi:10.1097/01.psy.0000097347.57237.2d · Cited by 111

Total Cholesterol Content of Erythrocyte Membranes Is Increased in Patients With Acute Coronary Syndrome

Tziakas, D. N., Kaski, J. C., Chalikias, G. K., Romero, C., Fredericks, S., Tentes, I. K., Kortsaris, A. X., Hatseras, D., & Holt, D. W. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.08.069 · Cited by 109

Bias in Associations of Emerging Biomarkers With Cardiovascular Disease

Tzoulaki, I., Siontis, K., Εvangelou, Ε., & Ioannidis, J. P. A. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.3018 · Cited by 108

Testosterone deficiency in the aging male

McBride, J. A., Carson, C. C., & Coward, R. M. (2015) · Therapeutic Advances in Urology · doi:10.1177/1756287215612961 · Cited by 109

Allopurinol reduces B-type natriuretic peptide concentrations and haemoglobin but does not alter exercise capacity in chronic heart failure

Gavin, A. D., & Struthers, A. D. (2005) · Heart · doi:10.1136/hrt.2004.040477 · Cited by 106

Effects of older age on fibrin D‐dimer, C‐reactive protein, and other hemostatic and inflammatory variables in men aged 60–79 years

Rumley, A., Emberson, J., Wannamethee, S. G., LENNON, L. T., Whincup, P. H., & Lowe, G. D. O. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.01889.x · Cited by 105

Are Markers of Inflammation More Strongly Associated with Risk for Fatal Than for Nonfatal Vascular Events?

Sattar, N. A., Murray, H. M., Welsh, P. I., Blauw, G. J., Buckley, B. M., Cobbe, S. M., de Craen, A. J. M., Lowe, G. D. O., Jukema, J. W., Macfarlane, P. W., et al. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000099 · Cited by 105

A randomized comparison of the effects of aspirin and clopidogrel on thrombotic risk factors and C‐reactive protein following myocardial infarction: the CADET trial

Woodward, M., Lowe, G. D. O., Francis, L., Rumley, A., & Cobbe, S. M. (2004) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2004.01017.x · Cited by 100

Erythrocytosis in a Large Cohort of Trans Men Using Testosterone: A Long-Term Follow-Up Study on Prevalence, Determinants, and Exposure Years

Madsen, M. C., van Dijk, D., Wiepjes, C. M., Conemans, E. B., Thijs, A., & den Heijer, M. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab089 · Cited by 91

Importance of Blood Rheology in the Pathophysiology of Atherothrombosis

Cowan, A. Q., Cho, D. J., & Rosenson, R. S. (2012) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-012-6402-4 · Cited by 91

Red blood cell distribution width as a prognostic marker in patients with heart failure and diabetes mellitus

Xanthopoulos, A. V., Giamouzis, G., Melidonis, A. J., Kitai, T., Paraskevopoulou, E., Paraskevopoulou, P., Patsilinakos, S. P., Triposkiadis, F. K., & Skoularigis, J. S. (2017) · Cardiovascular Diabetology · doi:10.1186/s12933-017-0563-1 · Cited by 89

Can haematological tests predict cardiovascular risk? The 2005 Kettle Lecture*

Lowe, G. D. O. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06021.x · Cited by 86

C-reactive protein and cardiovascular disease: Weighing the evidence

Lowe, G. D. O., & Pepys, M. B. (2006) · Current Atherosclerosis Reports · doi:10.1007/s11883-006-0040-x · Cited by 87

The associations of interleukin-6 (IL-6) and downstream inflammatory markers with risk of cardiovascular disease: The Caerphilly Study

Patterson, C., Smith, A. E., YARNELL, J. W. G., Rumley, A., Ben‐Shlomo, Y., & Lowe, G. D. O. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.09.030 · Cited by 88

Psychosocial, Hemostatic, and Inflammatory Correlates of Delayed Poststress Blood Pressure Recovery

Steptoe, A., & Marmot, M. G. (2006) · Psychosomatic Medicine · doi:10.1097/01.psy.0000227751.82103.65 · Cited by 85

Established and emerging coronary risk factors in patients with heterozygous familial hypercholesterolaemia

Neil, H. A. W., Seagroatt, V., Betteridge, D. J., Cooper, M. B., Durrington, P. N., Miller, J. P., Seed, M., Naoumova, R. P., Thompson, G. R., Huxley, R., et al. (2004) · Heart · doi:10.1136/hrt.2003.022764 · Cited by 84

High fibrinogen level is an independent predictor of presence and extent of coronary artery disease among Italian population

Novara Atherosclerosis Study Group (NAS), Luca, G. D., Verdoia, M., Cassetti, E., Schaffer, A., Cavallino, C., Bolzani, V., & Marino, P. N. (2010) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-010-0531-z · Cited by 83

Association of hematocrit value with cardiovascular morbidity and mortality in incident hemodialysis patients

Li, S., & Collins, A. J. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00425.x · Cited by 82

Heart rate and microinflammation in men: a relevant atherothrombotic link

Rogowski, O., Shapira, I., Shirom, A., Melamed, S., Toker, S., & Berliner, S. (2007) · Heart · doi:10.1136/hrt.2006.101949 · Cited by 83

Plasma and blood viscosity in the prediction of cardiovascular disease and mortality in the Scottish Heart Health Extended Cohort Study

Peters, S. A. E., Woodward, M., Rumley, A., Tunstall-Pedoe, H. D., & Lowe, G. D. O. (2016) · European Journal of Preventive Cardiology · doi:10.1177/2047487316672004 · Cited by 81

The effects of different alcoholic drinks on lipids, insulin and haemostatic and inflammatory markers in older men

Lowe, G. D. O., Shaper, G., Whincup, P. H., Rumley, A., Walker, M., LENNON, L. T., & Wannamethee, S. G. (2003) · Thrombosis and Haemostasis · doi:10.1160/th03-04-0221 · Cited by 80

The effect of periodontal therapy on cardiovascular risk markers: a 6‐month randomized clinical trial

Caúla, A. L., Lira‐Junior, R., Tinoco, E. M. B., & Fischer, R. G. (2014) · Journal Of Clinical Periodontology · doi:10.1111/jcpe.12290 · Cited by 84

Arterial and venous thrombosis by high platelet count and high hematocrit: 108 521 individuals from the Copenhagen General Population Study

Warny, M., Helby, J., Birgens, H., Bojesen, S. E., & Nordestgaard, B. G. (2019) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14574 · Cited by 80

Haemostatic/inflammatory markers predict 10-year risk of IHD at least as well as lipids: the Caerphilly collaborative studies

Yarnell, J. W. G. (2004) · European Heart Journal · doi:10.1016/j.ehj.2004.04.011 · Cited by 79

C‐reactive protein: associations with haematological variables, cardiovascular risk factors and prevalent cardiovascular disease

Woodward, M., Rumley, A., Lowe, G. D. O., & Tunstall‐Pedoe, H. (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04387.x · Cited by 78

Hematocrit and the risk of cardiovascular disease in a Japanese community: The Hisayama Study

Gotoh, S., Hata, J., Ninomiya, T., Hirakawa, Y., Nagata, M., Mukai, N., Fukuhara, M., Ikeda, F., Ago, T., Kitazono, T., et al. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.07.014 · Cited by 74

Erythrocyte sedimentation rate, coronary atherosclerosis, and cardiac mortality

Natali, A. (2003) · European Heart Journal · doi:10.1016/s0195-668x(02)00741-8 · Cited by 73

The mechanistic relationships between hemorheological characteristics and cardiovascular disease

Kensey, K. R. (2003) · Current Medical Research and Opinion · doi:10.1185/030079903125002289 · Cited by 71

Excessive Erythrocytosis and Cardiovascular Risk in Andean Highlanders

Corante, N., Anza‐Ramirez, C., Figueroa‐Mujíca, R., Macarlupú, J. L., Vizcardo‐Galindo, G. A., Bilo, G., Parati, G., Gamboa, J. L., Lèon‐Velarde, F., & Villafuerte, F. C. (2018) · High Altitude Medicine & Biology · doi:10.1089/ham.2017.0123 · Cited by 71

The relevance of coagulation in cardiovascular disease: what do the biomarkers tell us?

Rumley, A., & Lowe, G. D. O. (2014) · Thrombosis and Haemostasis · doi:10.1160/th14-03-0199 · Cited by 71

Associations of plasma pro‐inflammatory cytokines, fibrinogen, viscosity and C‐reactive protein with cardiovascular risk factors and social deprivation: the fourth Glasgow MONICA study

Welsh, P. I., Woodward, M., Rumley, A., & Lowe, G. D. O. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07133.x · Cited by 69

Cardiovascular Risks of Anemia Correction with Erythrocyte Stimulating Agents: Should Blood Viscosity Be Monitored for Risk Assessment?

Jeong, S., Cho, Y. I., Duey, M., & Rosenson, R. S. (2010) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-010-6239-7 · Cited by 62

The risk of thrombosis in essential thrombocythemia and polycythemia vera

Pearson, T. A. (2002) · Seminars in Oncology · doi:10.1016/s0093-7754(02)70148-6 · Cited by 61

Effect of cigarette smoking based on hematological parameters: comparison between male smokers and non-smokers

Asif, M., Karim, S., Umar, Z., Malik, A., Ismail, T., Chaudhary, A., Al-Qahtani, M. H., & Rasool, M. (2013) · Turkish Journal of Biochemistry · doi:10.5505/tjb.2013.68077 · Cited by 62

Renal function and cardiovascular mortality in elderly men: the role of inflammatory, procoagulant, and endothelial biomarkers

Wannamethee, S. G., Shaper, A. G., Lowe, G. D. O., LENNON, L. T., Rumley, A., & Whincup, P. H. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl402 · Cited by 58

Cardiovascular benefits of phlebotomy: relationship to changes in hemorheological variables

Holsworth, R., Cho, Y. I., Weidman, J. J., Sloop, G. D., & Cyr, J. A. S. (2013) · Perfusion · doi:10.1177/0267659113505637 · Cited by 61

Association of European population levels of thrombotic and inflammatory factors with risk of coronary heart disease: the MONICA Optional Haemostasis Study†

Yarnell, J., McCRUM, E. E., Rumley, A., Patterson, C., Salomaa, V. V., Lowe, G. D. O., & Evans, A. (2004) · European Heart Journal · doi:10.1093/eurheartj/ehi052 · Cited by 57

Time course of cigarette smoke-induced changes of systemic inflammation and muscle structure

Krüger, K., Dischereit, G., Seimetz, M., Wilhelm, J., Weißmann, N., & Mooren, F. C. (2015) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00074.2015 · Cited by 59

Relationship between serum cholesterol and indices of erythrocytes and platelets in the US population

Fessler, M. B., Rose, K. M., Zhang, Y., Jaramillo, R., & Zeldin, D. C. (2013) · Journal of Lipid Research · doi:10.1194/jlr.p037614 · Cited by 57

Collaborative meta-analysis of prospective studies of plasma fibrinogen and cardiovascular disease

Fibrinogen Studies Collaboration∗ (2004) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/01.hjr.0000114968.39211.01 · Cited by 56

Association among low whole blood viscosity, haematocrit, haemoglobin and diabetic retinopathy in subjects with type 2 diabetes

Irace, C., Scarinci, F., Scorcia, V., Bruzzichessi, D., Fiorentino, R., Randazzo, G., Scorcia, G. B., & Gnasso, A. (2010) · British Journal of Ophthalmology · doi:10.1136/bjo.2009.172601 · Cited by 54

Exercise hemorheology as a three acts play with metabolic actors: is it of clinical relevance?

Brun, J. ‐. (2002) · PubMed · Cited by 54

Insulin resistance, haemostatic and inflammatory markers and coronary heart disease risk factors in Type 2 diabetic men with and without coronary heart disease

Wannamethee, S. G., Lowe, G. D. O., Shaper, A. G., Rumley, A., LENNON, L. T., & Whincup, P. H. (2004) · Diabetologia · doi:10.1007/s00125-004-1491-7 · Cited by 54

First direct comparison of platelet reactivity and thrombolytic status between Japanese and Western volunteers: Possible relationship to the “Japanese paradox”

Gorog, D. A., Yamamoto, J., Saraf, S., Ishii, H., Ijiri, Y., Ikarugi, H., Wellsted, D. M., Mori, M., & Yamori, Y. (2010) · International Journal of Cardiology · doi:10.1016/j.ijcard.2010.07.002 · Cited by 53

A physiometer for simultaneous measurement of whole blood viscosity and its determinants: hematocrit and red blood cell deformability

Kim, B. J., Lee, Y. S., Zhbanov, A. I., & Yang, S. H. (2019) · The Analyst · doi:10.1039/c8an02135j · Cited by 53

Prognostic value of fibrinogen in patients with coronary artery disease and prediabetes or diabetes following percutaneous coronary intervention: 5-year findings from a large cohort study

Yuan, D., Jiang, P. X., Zhu, P., Jia, S., Zhang, C., Liu, Y., Liu, R., Xu, J., Tang, X., Zhao, X., et al. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-021-01335-1 · Cited by 56

Does sticky blood predict a sticky end? Associations of blood viscosity, haematocrit and fibrinogen with mortality in the West of Scotland

Woodward, M., Rumley, A., Tunstall‐Pedoe, H., & Lowe, G. D. O. (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04475.x · Cited by 51

Blood Transfusion and Risk of Venous Thromboembolism: A Population-Based Cohort Study

Lin, S.-Y., Chang, Y.-L., Yeh, H., Lin, C., & Kao, C. (2019) · Thrombosis and Haemostasis · doi:10.1055/s-0039-1697664 · Cited by 50

Regulatory effect of epigallocatechin gallate on the expression of C-reactive protein and other inflammatory markers in an experimental model of atherosclerosis

Ramesh, E., Geraldine, P., & Thomas, P. A. (2009) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2009.09.013 · Cited by 49

Prognostic impact of low‐shear whole blood viscosity in hypertensive men

Ciuffetti, G., Schillaci, G., Lombardini, R., Pirro, M., Vaudo, G., & Mannarino, E. (2005) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2005.01437.x · Cited by 50

In vitro and ex vivo measurement of the biophysical properties of blood using microfluidic platforms and animal models

Kang, Y. J., & Lee, S. J. (2018) · The Analyst · doi:10.1039/c8an00231b · Cited by 50

Stress-Induced Hyperviscosity in the Pathophysiology of Takotsubo Cardiomyopathy

Cecchi, E., Parodi, G., Giglioli, C., Passantino, S., Bandinelli, B., Liotta, A. A., Bellandi, B., Cioni, G., Costanzo, M. R., Abbate, R., et al. (2013) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2013.01.304 · Cited by 49

Red blood cell adhesiveness/aggregation, C-reactive protein, fibrinogen, and erythrocyte sedimentation rate in healthy adults and in those with atherosclerotic risk factors

Fusman, G., Mardi, T., Justo, D., Rozenblat, M., Rotstein, R., Zeltser, D., Rubinstein, A., Koffler, M., Shabtai, E. L., Berliner, S. A., et al. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02539-0 · Cited by 49

Micro-Viscometer for Measuring Shear-Varying Blood Viscosity over a Wide-Ranging Shear Rate

Kim, B. G., Lee, S. J., Jee, S., Atajanov, A., & Yang, S. H. (2017) · Sensors · doi:10.3390/s17061442 · Cited by 48

Haematocrit, type 2 diabetes, and endothelium-dependent vasodilatation of resistance vessels

Natali, A., Toschi, E., Baldeweg, S. E., Casolaro, A., Baldi, S., Sironi, A. M., Yudkin, J. S., & Ferrannini, E. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi113 · Cited by 48

Associations of adiponectin with metabolic and vascular risk parameters in the British Regional Heart Study reveal stronger links to insulin resistance-related than to coronory heart disease risk-related parameters

Wannamethee, S. G., Tchernova, J., Whincup, P. H., Lowe, G. D. O., Rumley, A., Brown, K. E., Cherry, L., & Sattar, N. A. (2007) · International Journal of Obesity · doi:10.1038/sj.ijo.0803544 · Cited by 48

Fibrinogen, Viscosity and White Blood Cell Count Predict Myocardial, but not Cerebral Infarction: Evidence from the Caerphilly and Speedwell Cohort

Pickering, J. E., Elwood, P., Bayer, A. J., Ebrahim, S. B. J., & Baker, I. A. (2002) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613020 · Cited by 47

Plasma lipid peroxides: relationships to cardiovascular risk factors and prevalent cardiovascular disease

Rumley, A. G., Woodward, M., Rumley, J., Rumley, J., & Lowe, G. D. O. (2004) · QJM · doi:10.1093/qjmed/hch130 · Cited by 46

Hematocrit Predicts Long-Term Mortality in a Nonlinear and Sex-Specific Manner in Hypertensive Adults

Paul, L. J., Jeemon, P., Hewitt, J., McCallum, L., Higgins, P., Walters, J., McClure, J., Dawson, J., Meredith, P., Jones, G. C., et al. (2012) · Hypertension · doi:10.1161/hypertensionaha.112.191510 · Cited by 46

Earthing (Grounding) the Human Body Reduces Blood Viscosity—a Major Factor in Cardiovascular Disease

Chevalier, G., Sinatra, S. T., Oschman, J. L., & Delany, R. M. (2012) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2011.0820 · Cited by 45

Blood Pressure and Hematocrit in Diabetes and the Role of Endothelial Responses in the Variability of Blood Viscosity

Salazar-Vázquez, B. Y., Intaglietta, M., Rodríguez‐Morán, M., & Guerrero‐Romero, F. (2006) · Diabetes Care · doi:10.2337/dc06-0323 · Cited by 45

Elevated, combined serum free light chain levels and increased mortality: a 5-year follow-up, UK study

Anandram, S., Assi, L. K., Lovatt, T. J., Parkes, J., Taylor, J., Macwhannell, A., Jacob, A. O., Handa, S., Harding, S. J., & Basu, S. (2012) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2012-200910 · Cited by 44

Erythrocyte sedimentation rate – an old marker with new applications

Bocheń, K., Krasowska, A., Milaniuk, S., Kulczyńska, M., Prystupa, A., & Dzida, G. J. (2011) · Journal of Pre-Clinical and Clinical Research · Cited by 43

Arterial stiffness and cumulative inflammatory burden in rheumatoid arthritis: a dose–response relationship independent of established cardiovascular risk factors

Crilly, M., Кумар, В., Clark, H. J., SCOTT, N. W., MacDonald, A. G., & Williams, D. J. (2009) · Lara D. Veeken · doi:10.1093/rheumatology/kep305 · Cited by 41

Erythrocyte sedimentation rate: is it a useful risk marker for coronary heart disease?

Rapaport, E. (2000) · European Heart Journal · doi:10.1053/euhj.2000.2236 · Cited by 8

Viscoelasticity and Red Blood Cell Aggregation in Patients with Coronary Heart Disease

Hahn, R. T., Müller-Seydlitz, P. M., Jöckel, K., Hubert, H., & Heimburg, P. (1989) · Angiology · doi:10.1177/000331978904001010 · Cited by 20

Erythrocyte sedimentation rate and coronary heart disease in elderly patients.

Kirkeby, O. J., & Risöe, C. (1986) · PubMed

Dynamic changes of erythropoietin and hemorheology in patients with CHD before and after treatment and effect on blood viscosity

Zhang, J. (2011) · Zhonghua laonian xin-nao-xueguanbing zazhi

Hematocrit and coronary heart disease.

Mayer, G. A. (1965) · PubMed Central · Cited by 21